Succimer
Lead Poisoning
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Small moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Lead Poisoning cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
Succimer is also rated in:
blast phase chronic myelogenous leukemia, BCR-ABL1 positiveDormant
CC
Indicative ·
43 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →